ASCO GUIDELINES Bundle

Estrogen and Progesterone Receptor Testing in Breast Cancer

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1199868

Contents of this Issue

Navigation

Page 11 of 13

12 Diagnosis Figure 3. Internal Controls A B C D Figure legend: Examples of internal control analysis in ER stains. Panel A (200×) illustrates an ER negative invasive cancer with an adjacent internal normal duct control (*) with optimal staining (nuclear staining varying from weak to very strong with alternating clusters of negative cells). Panel B (200×) is an example of an unexpectedly weak stain result in both the grade 1 invasive cancer and the normal duct internal controls (*). is result, although positive, raises concern about possible pre-analytic variables effecting the assay or, if these are deemed appropriate, that at the level of analytic sensitivity of the assay may be too low (especially to detect ER Low Positive results). Panel C (400×) is negative for ER expression both in the in the invasive cancer and the internal control duct (*) . e assay should be repeated and a investigation for potential causes of negative internal controls performed (including both pre-analytic and analytic factors). If internal controls remain negative and this issue appears isolated to this sample, the test should be reported as "Cannot be determined" (indeterminate; uninterpretable due to negative internal controls, possible pre-analytical tissue preservation issues). Panel D (200×) shows an invasive cancer with no ER staining and internal control columnar cell epithelium (*) with uniformly strong nuclear staining (as expected). ese results help support that there were no serious issues with the pre-analytical and analytic phases. However, such strong positive internal controls are less optimal to evaluate how well the assay is able to detect low levels of ER expression (evaluation of non-columnar cell, normal duct controls is more optimal, as in Panel A). * * * * * * * * * * * * * * *

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Estrogen and Progesterone Receptor Testing in Breast Cancer